PF-07258669

CAS No. 2755890-53-8

PF-07258669( —— )

Catalog No. M36282 CAS No. 2755890-53-8

PF-07258669 is a selective melanocortin 4 receptor (MC4) antagonist used in the study of cachexia and loss of appetite.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 1606 In Stock
10MG 2613 In Stock
25MG 5159 In Stock
50MG 8082 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    PF-07258669
  • Note
    Research use only, not for human use.
  • Brief Description
    PF-07258669 is a selective melanocortin 4 receptor (MC4) antagonist used in the study of cachexia and loss of appetite.
  • Description
    PF-07258669 is a melanocortin-4 receptor (MC4) antagonist. PF-07258669 can be used for the research of cachexia, anorexia, or anorexia nervosa.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    Melanocortin Receptor
  • Recptor
    Melanocortin Receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2755890-53-8
  • Formula Weight
    462.52
  • Molecular Formula
    C25H27FN6O2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C([C@H](C)C=1C=C(OC)N=CC1F)(=O)N2C[C@@]3(NC=4C(CC3)=CC(=C(C)N4)C=5N=CC=CN5)CC2
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Christopher Ryan BUTLER, et al. Spiro compounds as melanocortin 4 receptor antagonists and uses thereof. Patent. WO2021250541A1.
molnova catalog
related products
  • PG 106

    Selective hMC3 receptor antagonist (IC50 = 210 nM). Exhibits no activity at hMC4 receptors and hMC5 receptors.

  • PF-00446687 hydrochl...

    PF-00446687 hydrochloride (PF-446687) is a potent, selective melanocortin-4 receptor (MC4R) agonist with EC50 of 12 nM.

  • Neuropeptide EI, rat

    Displays functional MCH-antagonist and MSH-agonist activity in different behavioral paradigms.